問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-05-10 - 2025-04-30
Condition/Disease
xxxxxx
Test Drug
SerpinPCSterile Water for Injection 10mL vial
Participate Sites3Sites
Recruiting3Sites
2024-09-01 - 2026-12-31
amlitelimab
Participate Sites2Sites
Recruiting2Sites
2022-05-02 - 2026-09-30
Sibeprenlimab (VIS649) Sibeprenlimab (VIS649)
Participate Sites6Sites
Recruiting6Sites
2022-07-01 - 2023-03-16
PF-06838435 (Fidanacogene elaparvovec)
2022-04-01 - 2026-06-30
Not yet recruiting2Sites
Recruiting4Sites
2021-11-15 - 2023-12-30
Ibuprofen Modified-Release Tablets 800 mg
Participate Sites9Sites
Recruiting9Sites
2022-11-01 - 2028-04-30
Efgartigimod PH20 SC
2023-06-01 - 2026-06-08
Dazodalibep
Participate Sites4Sites
2022-06-01 - 2026-06-30
Extensive-stage Small-cell Lung Cancer
Ifinatamab Deruxtecan (I-DXd)
2016-01-01 - 2019-08-31
Non-Small Cell Lung Cancer (NSCLC)
AZD9291
Terminated8Sites
Division of Hematology & Oncology
未分科
全部
